Tag: dabrafenib

Clinical trial reveals positive results for treating children with rare gliomas

by Jen Brogan | Nov 28, 2023 | News | 0

Tafinlar and Mekinist led to a 56% overall response rate in children with BM-HGG

NHS green light for Novartis skin cancer combo

by Selina McKee | Oct 18, 2018 | News | 0

The NHS now has three months to ensure that Novartis’ combination therapy dabrafenib/trametinib is routinely available to eligible skin cancer patients, after cost regulators published guidance backing funds for the treatment.

Breakthrough badge for Novartis’ skin cancer combo

by Selina McKee | Oct 24, 2017 | News | 0

A targeted combination therapy being developed by Novartis as adjuvant treatment for patients with a certain type of melanoma has been assigned breakthrough designation in the US.

EU OKs Novartis’ Tafinlar/Mekinist combo for lung cancer

by Selina McKee | Apr 3, 2017 | News | 0

European regulators have expanded the scope of Novartis’ Tafinlar/Mekinist combination to include the treatment of patients with a certain form of lung cancer.